Yeonhee Park to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Yeonhee Park has written about Randomized Controlled Trials as Topic.
Connection Strength
0.124
-
A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial. Contemp Clin Trials. 2019 11; 86:105852.
Score: 0.124
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.